Found: 4
Select item for more details and to access through your institution.
Inhibition of sclerostin by monoclonal antibody enhances bone healing and improves bone density and strength of nonfractured bones.
- Published in:
- Journal of Bone & Mineral Research, 2011, v. 26, n. 5, p. 1012, doi. 10.1002/jbmr.307
- By:
- Publication type:
- Article
Inhibition of Sclerostin by Monoclonal Antibody Increases Bone Formation, Bone Mass, and Bone Strength in Aged Male Rats.
- Published in:
- Journal of Bone & Mineral Research, 2010, v. 25, n. 12, p. 2371, doi. 10.1002/jbmr.182
- By:
- Publication type:
- Article
One Year of Transgenic Overexpression of Osteoprotegerin in Rats Suppressed Bone Resorption and Increased Vertebra Bone Volume, Density, and Strength.
- Published in:
- Journal of Bone & Mineral Research, 2009, v. 24, n. 7, p. 1234, doi. 10.1359/JBMR.090215
- By:
- Publication type:
- Article
RANKL Inhibition With Osteoprotegerin Increases Bone Strength by Improving Cortical and Trabecular Bone Architecture in Ovariectomized Rats.
- Published in:
- Journal of Bone & Mineral Research, 2008, v. 23, n. 5, p. 672, doi. 10.1359/JBMR.080109
- By:
- Publication type:
- Article